137 related articles for article (PubMed ID: 12575739)
1. Drug targeting by solid lipid nanoparticles for dermal use.
Santos Maia C; Mehnert W; Schaller M; Korting HC; Gysler A; Haberland A; Schäfer-Korting M
J Drug Target; 2002 Sep; 10(6):489-95. PubMed ID: 12575739
[TBL] [Abstract][Full Text] [Related]
2. Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.
Schlupp P; Blaschke T; Kramer KD; Höltje HD; Mehnert W; Schäfer-Korting M
Skin Pharmacol Physiol; 2011; 24(4):199-209. PubMed ID: 21346400
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles as drug carriers for topical glucocorticoids.
Maia CS; Mehnert W; Schäfer-Korting M
Int J Pharm; 2000 Mar; 196(2):165-7. PubMed ID: 10699710
[TBL] [Abstract][Full Text] [Related]
4. In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use.
Lombardi Borgia S; Schlupp P; Mehnert W; Schäfer-Korting M
Eur J Pharm Biopharm; 2008 Feb; 68(2):380-9. PubMed ID: 17574402
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake.
Sivaramakrishnan R; Nakamura C; Mehnert W; Korting HC; Kramer KD; Schäfer-Korting M
J Control Release; 2004 Jul; 97(3):493-502. PubMed ID: 15212881
[TBL] [Abstract][Full Text] [Related]
6. Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin.
Haberland A; Santos Maia C; Jores K; Dürrfeld M; Mehnert W; Schimke I; Christ B; Schäfer-Korting M
ALTEX; 2003; 20(1):3-9. PubMed ID: 12579349
[TBL] [Abstract][Full Text] [Related]
7. Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.
Gysler A; Kleuser B; Sippl W; Lange K; Korting HC; Höltje HD; Korting HC
Pharm Res; 1999 Sep; 16(9):1386-91. PubMed ID: 10496654
[TBL] [Abstract][Full Text] [Related]
8. Application of nanoparticles in percutaneous delivery of active ingredients in cosmetic preparations.
Khezri K; Saeedi M; Maleki Dizaj S
Biomed Pharmacother; 2018 Oct; 106():1499-1505. PubMed ID: 30119225
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery.
Lv Q; Yu A; Xi Y; Li H; Song Z; Cui J; Cao F; Zhai G
Int J Pharm; 2009 May; 372(1-2):191-8. PubMed ID: 19429280
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
Padois K; Cantiéni C; Bertholle V; Bardel C; Pirot F; Falson F
Int J Pharm; 2011 Sep; 416(1):300-4. PubMed ID: 21704140
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential.
Ferreira M; Silva E; Barreiros L; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2016 Oct; 512(1):14-21. PubMed ID: 27530292
[TBL] [Abstract][Full Text] [Related]
13. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
14. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
[TBL] [Abstract][Full Text] [Related]
15. Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin.
Charoenputtakun P; Li SK; Ngawhirunpat T
Int J Pharm; 2015 Nov; 495(1):318-328. PubMed ID: 26325320
[TBL] [Abstract][Full Text] [Related]
16. Cosmetic applications for solid lipid nanoparticles (SLN).
Wissing SA; Müller RH
Int J Pharm; 2003 Mar; 254(1):65-8. PubMed ID: 12615411
[TBL] [Abstract][Full Text] [Related]
17. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.
Gysler A; Lange K; Korting HC; Schäfer-Korting M
Pharm Res; 1997 Jun; 14(6):793-7. PubMed ID: 9210199
[TBL] [Abstract][Full Text] [Related]
18. Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro.
Lange K; Gysler A; Bader M; Kleuser B; Korting HC; Schäfer-Korting M
Pharm Res; 1997 Dec; 14(12):1744-9. PubMed ID: 9453063
[TBL] [Abstract][Full Text] [Related]
19. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.
Jenning V; Gysler A; Schäfer-Korting M; Gohla SH
Eur J Pharm Biopharm; 2000 May; 49(3):211-8. PubMed ID: 10799811
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles.
Zhang J; Smith E
J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
